Facebook
Twitterhttps://dataverse.harvard.edu/api/datasets/:persistentId/versions/1.3/customlicense?persistentId=doi:10.7910/DVN/YJCLHRhttps://dataverse.harvard.edu/api/datasets/:persistentId/versions/1.3/customlicense?persistentId=doi:10.7910/DVN/YJCLHR
The ACCRA Cost of Living Index (COLI) is a measure of living cost differences among urban areas compiled by the Council for Community and Economic Research. Conducted quarterly, the index compares the price of goods and services among approximately 300 communities in the United States and Canada. This Microsoft Excel file contains the average prices of goods and services published in the ACCRA Cost of Living Index since 1990.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
Major wage settlements, including number of agreements, number of employees, average duration of agreements, first year average percentage wage adjustment, and annual average percentage wage adjustment, by jurisdiction, industry, sector, and cost of living adjustment (COLA), quarterly, from 1977 to 2020.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Inflation Rate in Canada decreased to 2.20 percent in October from 2.40 percent in September of 2025. This dataset provides - Canada Inflation Rate - actual values, historical data, forecast, chart, statistics, economic calendar and news.
Facebook
TwitterThese are peer-reviewed supplementary materials for the article 'The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries' published in the Journal of Comparative Effectiveness Research.Supplementary Tables and FiguresSupplementary Table 1: Economic Outcomes of Probabilistic Scenario Analyses Supplementary Figure 1: Tornado Diagrams for Per-Patient Incremental Cost – US AnalysisSupplementary Figure 2: Tornado Diagrams for Per-Patient Incremental Cost – Canada AnalysisSupplementary Figure 3: Tornado Diagrams for Per-Patient Incremental Cost – UK AnalysisSupplementary Figure 4: Tornado Diagrams for Per-Patient Incremental Cost – Sweden AnalysisSupplementary Figure 5: Tornado Diagrams for Per-Patient Incremental Cost – Germany AnalysisSupplementary Figure 6: Tornado Diagrams for Per-Patient Incremental Cost – France AnalysisSupplementary Figure 7: Tornado Diagrams for Per-Patient Incremental Cost – Italy AnalysisSupplementary Figure 8: Tornado Diagrams for Per-Patient Incremental Cost – Spain AnalysisSupplementary Figure 9: Tornado Diagrams for Per-Patient Incremental Cost – Belgium AnalysisSupplementary Figure 10: Tornado Diagrams for Per-Patient Incremental Cost – The Netherlands AnalysisSupplementary MethodsCost Inputs for GermanyCost Inputs for FranceCost Inputs for The NetherlandsSupplementary Material ReferencesAim: According to the results of the MASTRO I living systematic review and meta-analysis, use of the EmboTrap Revascularization Device in the treatment of acute ischemic stroke (AIS) results in higher rates of good functional outcomes (90-day modified Rankin Scale [mRS] 0–2) compared with use of the Trevo Retriever or the Solitaire™ Revascularization Device. The aim of this analysis was to assess the potential economic impact of achieving improved functional outcomes for three commonly used stent retrievers (SRs) in the treatment of AIS. Methods: An economic modelwith short-term and long-term costs, representing a healthcare system perspective was developed using a decision tree to simulate a cohort of 1000 hypothetical patients treated for AIS with mechanical thrombectomy (MT) using EmboTrap, Trevo or Solitaire SRs. Based on the proportion of patients who achieved a 90-day mRS score of 0–2 or 3–5 for each device reported in MASTRO I (excluding patients not surviving after 90 days), this model estimated per-patient costs and the associated incremental cost savings. Results are reported from the healthcare system perspective in the US, Canada, the UK, Sweden, Germany, France, Italy, Spain, Belgium and The Netherlands. Results: Across all ten countries, the use of EmboTrap during MT was associated with the lowest short-term (ranging from €8412 in Italy to $66,525 in the US), long-term (ranging from €5249 in Italy to $25,757 in the US) and total (ranging from €13,661 in Italy to $92,282 in the US) per-patient costs. The total per-patient cost was higher with Trevo (ranging from €14,601 in Italy to $97,487 in the US) and Solitaire (ranging from €14,840 in Italy to $98,814 in the US). Cost savings were highest when comparing EmboTrap versus Solitaire, followed by EmboTrap versus Trevo, with Trevo versus Solitaire having the smallest cost savings. Results of sensitivity and scenario analyses supported the robustness of the basecase results. Conclusion: Across the ten countries, treating patients with AIS with EmboTrap resulted in lower short-term, long-term and total costs to the payer. With rising healthcare costs and limited hospital budgets, these results suggest EmboTrap proves to be an evidence-based economical choice of SR for hospitals and healthcare systems.
Facebook
TwitterThis Gallup poll aims to collect the opinions of Canadians, on topics currently of interest to them, and the government. While there are some questions directly about politics and political leaders, the majority of the variables deal with current events topics, and subjects of political importance. Other subjects include birth control, development of the country, unions, and lotteries. The respondents were also asked questions so that they could be grouped according to geographic and social variables. Topics of interest include: American investment in Canada; birth control pills; whether Canada is becoming socialistic; changes in the cost of living; the development of Canada as a nation; federal elections; John Diefenbaker's performance as leader of the opposition; L.B. Johnson's performance as the President of the United States; labour union politics; Lester Pearson's performance as Prime Minister; a lottery to help pay for health and welfare; Tommy Douglas' performance as leader of the NDP; union membership; and voting behaviour. Basic demographics variables are also included.
Facebook
TwitterAverage hourly and weekly wage rate, and median hourly and weekly wage rate by North American Industry Classification System (NAICS), type of work, gender, and age group.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Consumer Price Index CPI in Canada increased to 165.30 points in October from 164.90 points in September of 2025. This dataset provides the latest reported value for - Canada Consumer Price Index (CPI) - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.
Facebook
TwitterMonthly indexes for major components and special aggregates of the Consumer Price Index (CPI), not seasonally adjusted, for Canada, provinces, Whitehorse, Yellowknife and Iqaluit. Data are presented for the current month and previous four months. The base year for the index is 2002=100.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Facebook
Twitterhttps://dataverse.harvard.edu/api/datasets/:persistentId/versions/1.3/customlicense?persistentId=doi:10.7910/DVN/YJCLHRhttps://dataverse.harvard.edu/api/datasets/:persistentId/versions/1.3/customlicense?persistentId=doi:10.7910/DVN/YJCLHR
The ACCRA Cost of Living Index (COLI) is a measure of living cost differences among urban areas compiled by the Council for Community and Economic Research. Conducted quarterly, the index compares the price of goods and services among approximately 300 communities in the United States and Canada. This Microsoft Excel file contains the average prices of goods and services published in the ACCRA Cost of Living Index since 1990.